ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,549Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 53

$1.78M Total Retail Price of All Prescriptions

Rank: 2 out of 53

578 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 578 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 4,891 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

61% of this provider’s prescriptions were for brand-name drugs, compared to an average of 46%.

Prescription Price

$187 was the average price of a prescription from this provider, compared to $123 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
SYNTHROID 948 474 1 2
PEN NEEDLE 413 188 2 4
HUMALOG 399 145 3 11
LANTUS SOLOSTAR 315 142 4 5
METFORMIN HCL 287 179 5 3
WELCHOL 263 134 6 50
CRESTOR 254 144 7 20
LEVEMIR FLEXPEN 233 132 8 23
LANTUS 218 137 9 7
AMLODIPINE BESYLATE 190 149 10 18
ONGLYZA 169 134 11 41
INSULIN SYRINGE 154 87 12 9
PRAVASTATIN SODIUM 143 106 13 17
POTASSIUM CHLORIDE 137 66 14 30
GABAPENTIN 135 60 15 21
LEVEMIR 133 64 16 42
LEVOTHYROXINE SODIUM 132 52 17 1
NIASPAN 128 83 18 49
SPIRIVA 120 33 19 125
VICTOZA 3-PAK 120 33 19 40
JANUVIA 114 66 21 14
METOPROLOL SUCCINATE 99 52 22 34
BYETTA 99 21 22 52
BENICAR 96 57 24 137
FUROSEMIDE 95 47 25 16
OMEPRAZOLE 91 38 26 24
METFORMIN HCL ER 87 65 27 22
NOVOLOG FLEXPEN 86 42 28 13
CYMBALTA 83 53 29 68
TRICOR 78 34 30 45
BENICAR HCT 75 53 31 105
NOVOLOG 72 21 32 19
TEKTURNA 71 51 33 149
ALLOPURINOL 71 15 33 51
LOSARTAN POTASSIUM 70 37 35 27
ULTICARE 69 30 36 158
HYDROCHLOROTHIAZIDE 68 40 37 28
KLOR-CON M20 67 15 38 82
LISINOPRIL 67 39 38 8
DIOVAN 66 44 40 75
LOVAZA 65 35 41 38
BYSTOLIC 60 15 42 72
SPIRONOLACTONE 56 18 43 59
GLIMEPIRIDE 56 28 43 10
NEXIUM 55 32 45 35
METHIMAZOLE 53 42 46 25
TRILIPIX 50 27 47 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.